These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39127252)

  • 1. Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart Failure.
    Tan YJ; Ong SC
    Value Health; 2024 Aug; ():. PubMed ID: 39127252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.
    Neilson AR; Jones GT; Macfarlane GJ; Pathan EM; McNamee P
    Eur J Health Econ; 2022 Nov; 23(8):1357-1369. PubMed ID: 35113270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country.
    Yousefi M; Nahvijou A; Sari AA; Ameri H
    Value Health Reg Issues; 2021 May; 24():57-66. PubMed ID: 33508752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
    Lamu AN; Olsen JA
    Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.
    Meunier A; Soare A; Chevrou-Severac H; Myren KJ; Murata T; Longworth L
    Appl Health Econ Health Policy; 2022 Jan; 20(1):119-131. PubMed ID: 34554442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis.
    Yu L; Yang H; Lu L; Fang Y; Zhang X; Li S; Li C
    Health Qual Life Outcomes; 2024 Aug; 22(1):61. PubMed ID: 39113080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.
    Liu T; Li S; Wang M; Sun Q; Chen G
    Patient; 2020 Oct; 13(5):537-555. PubMed ID: 32382953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study.
    Jiang L; Zhou H; Yang Q; Luo X; Huang D
    Qual Life Res; 2024 Mar; 33(3):805-816. PubMed ID: 38148367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation, cross-cultural adaptation, and psychometric validation of the Malay version of the Assessment of Quality of Life-6 Dimensions (Malay-AQoL-6D) instrument among Malaysians living with chronic heart failure.
    Tan YJ; Ong SC; Goh SP; Chen G; Yong VS; Khor WW; Kan YM; Choong YY; Zameram AM; Tan LY; Voo JYH; Lam KK; Yen CH; Wahab MJA; Abdulla ZB
    J Patient Rep Outcomes; 2024 Jul; 8(1):79. PubMed ID: 39052204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
    Moore A; Young CA; Hughes DA
    Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.
    Ameri H; Yousefi M; Yaseri M; Nahvijou A; Arab M; Akbari Sari A
    Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):89-96. PubMed ID: 30173585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D.
    Cox IA; Campbell J; de Graaff B; Otahal P; Corte TJ; Moodley Y; Hopkins P; Macansh S; Walters EH; Palmer AJ
    Qual Life Res; 2023 Feb; 32(2):473-493. PubMed ID: 35927542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.
    Meregaglia M; Borsoi L; Cairns J; Tarricone R
    Eur J Health Econ; 2019 Mar; 20(2):181-193. PubMed ID: 28948436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
    PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis.
    Yang F; Wong CKH; Luo N; Piercy J; Moon R; Jackson J
    Eur J Health Econ; 2019 Nov; 20(8):1195-1206. PubMed ID: 31338698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia.
    Abdin E; Chong SA; Seow E; Verma S; Tan KB; Subramaniam M
    Qual Life Res; 2019 Jan; 28(1):177-186. PubMed ID: 30382480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping study of papillary thyroid carcinoma in China: Predicting EQ-5D-5L utility values from FACT-H&N.
    Huang D; Peng J; Chen N; Yang Q; Jiang L
    Front Public Health; 2023; 11():1076879. PubMed ID: 36908441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
    Yang Q; Yu XX; Zhang W; Li H
    Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.